Skip to main content
. 2023 Aug 30;11(2):125–131. doi: 10.1093/nop/npad057

Table 1.

Descriptive Data

All Grade 4 Grade 2-3
Cases Total, n (%) 1231 754 (61) 477 (39)
Male/female, % 59/41 61/39 56/44
Surgery Biopsy/resection, % 26/74 27/73 26/74
Prevalence of antidepressant medicationa Total, n (%) 346 (28) 205 (27) 141 (30)
Male, n (%) 200 (28) 121 (26) 79 (30)
Female, n (%) 146 (29) 84 (28) 62 (30)
Selective serotonin reuptake inhibitor (SSRI)/non-SSRIb Total, % 58/42 60/40 57/43
Mean agec Years 63 64 59
Male/female, years 62/64 63/66 59/59
Mean survivald Months 19 16 27

aPercentage of patients treated with antidepressants compared to group or subgroup total.

bDistribution of SSRI or non-SSRI treatment within groups.

cAt time of diagnosis.

dFrom time of surgery.